Ray Shepherd, MD
Pulmonary Disease · Richmond, VANPI 1639263940
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,800 of the $11,607 with a category attached, or 75.8%. Cook Incorporated accounts for 75.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $8,679 and has fallen 99.4% since, to $54 in 2025.
Across 38 payments — averaging $305.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$9K
- Cook Medical LLC$1K
- Johnson & Johnson$972
- Intuitive Surgical$270
- Pulmonx Corporation$174
- Steris Corporation$158
- plus $209 from 4 others
Across 17 payments — averaging $17,148 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Galvanize Therapeutics, Inc$287K
- Gyrus ACMI, Inc.$2K
- Spiration, Inc.$2K
What the payments were for
- Speaking & faculty fees$8,80076%
- Travel & lodging$1,70115%
- Food & beverage$1,10610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 3 | $8,800 |
| Cook Medical LLC | 16 | $1,024 |
| Johnson & Johnson | 5 | $972 |
| Intuitive Surgical | 3 | $270 |
| Pulmonx Corporation | 6 | $174 |
| Steris Corporation | 1 | $158 |
| Galvanize Therapeutics, Inc | 1 | $81 |
| United Therapeutics Corporation | 1 | $54 |
| Olympus America Inc. | 1 | $45 |
| Pinnacle Biologics, Inc | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,607 in reported general payments places this provider in the 80th percentile of 317 pulmonary disease providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 60 | $49,193 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 70 | $40,797 |
| Spiriva HandihalerTiotropium Bromide | 17 | $12,762 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 19 | $12,546 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 48 | $10,906 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $7,669 |
| Esomeprazole Magnesium | 17 | $2,234 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 58 | $1,829 |
| Ipratropium Bromide | 31 | $1,182 |
| Ventolin HfaAlbuterol Sulfate | 17 | $924 |
| Fluticasone Propionate | 20 | $417 |
| Omeprazole | 13 | $264 |
| Azithromycin | 22 | $156 |
| Prednisone | 48 | $131 |
| Montelukast Sodium | 27 | $130 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Richmond
- Sujoy GillRichmond$296K
- Patricia SimeRichmond$113K
- Shilpa JohriRichmond$37K
- Apostolos PerelasRichmond$31K
- John SentzRichmond$20K
- Glenn GiesselRichmond$14K
- Nauman ChaudaryRichmond$13K
- Michael MistrettaRichmond$13K
- Steven NathanFalls Church$1.5M
- Omar MinaiHopewell$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.